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This study was conducted to provide information on the genetic diversity of human parv-
ovirus  B19 (B19V) circulating in the municipality of Niterói, Rio de Janeiro, Southeast Brazil
during 1996–2006, a period with two distinct outbreaks of B19V infection: 1999–2000 and
2004–2005. A total of 27 sera from patients with erythema infectiosum and ﬁve sera from
HIV-infected patients that tested positive for B19V DNA during the study period were ana-
lyzed. To genotype B19V strains, a semi-nested PCR for partial ampliﬁcation of the capsid
gene  was performed and sequence analysis revealed that 31 sequences belonged to subgeno-
type 1a (G1a) of the main genotype 1 and one sequence was characterized as subgenotype 3b
(G3b). The phylogenetic tree supported the division of the G1a into two well-deﬁned clades
with 1.3% of divergence. The low diversity of the G1a strains may be explained by the fact
that  all patients had acute B19V infection and 30/32 sera were collected during two distinct
outbreaks. The G3b strain was from an HIV-infected patient who seroconverted to anti-B19IgG  antibodies in September/2005. This is the ﬁrst report of G3b in the state of Rio de Janeiro.
©  2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an
open  access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
tiﬁed: (i) genotype 1, with subtypes 1a (the prototypic virus)
he human parvovirus B19 (B19V), a member of the
rythroparvovirus genus (Parvoviridae family), is a small, non-Please cite this article in press as: Cubel Garcia RC, et al. Molecular div
infectiosum in Brazil. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bji
nveloped icosahedral virus composed of two structural
roteins VP1 (83 kDa) and VP2 (58 kDa) surrounding a lin-
ar single-stranded DNA genome of approximately 5.6 Kb.1,2
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Currently, three distinct genotypes of B19V have been iden-ersity of human parvovirus B19 during two outbreaks of erythema
d.2016.11.002
and 1b; (ii) genotype 2 (A6 and LaLi strains); and (iii) geno-
type 3, with subtypes 3a (V9 strain) and 3b (D91.1 strain).2–4
Genotype 1 is the most prevalent worldwide, genotype 2 has
lsevier Editora Ltda. This is an open access article under the CC
.
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been detected in patients born before 1973 from European
countries, the United States and Brazil, and genotype 3 pre-
dominates in parts of West Africa.2,5
The most common clinical presentation of B19V infec-
tion in immunocompetent individuals is the erythema
infectiosum (EI) or ﬁfth disease, a self-limited childhood exan-
thema characterized by a “slapped-cheek” rash. Adults with
EI, particularly women, frequently present clinically with
arthropathy. It is assumed that EI and the joint symptoms are
the result of deposition of immune complexes.2,6,7
Previous studies conducted by our group demonstrated
that B19V infection is a common event in schoolchildren aged
ﬁve to nine years old and that EI outbreaks seem to occur every
4–5 years.6,7 All three genotypes of B19V have been reported in
patients presenting with acute and/or persistent B19V infec-
tion in Brazil.5,8–12 Nonetheless, there is a lack of information
regarding the genotypes of B19V circulating during outbreaks
of EI in our country.
This study was conducted to provide information on the
genetic diversity of B19V circulating during a period span-
ning two outbreaks of EI in the municipality of Niterói, Rio
de Janeiro state. In addition, B19V strains from HIV-positive
patients infected during the study period were also character-
ized.
The serum samples analyzed in this study were collected
during a 10-year-period (1996–2006) from 131 patients with
exanthematic disease, 28 of them with arthropathy, attending
the Infectious Diseases Department, Antonio Pedro University
Hospital, Federal Fluminense University in Niterói, RJ. These
sera had previously tested positive for anti-B19V IgM using
a commercial enzyme immunoassay (Biotrin International,
Dublin, Ireland).6,7 Of 131 patients, 79 were female. Their ages
ranged from 9 months to 54 years. In addition, sera from ﬁve
HIV-infected adult patients who  attended the general med-
ical outpatient clinic for routine care and were found to be
positive for B19V DNA during the study period were also exam-
ined. These cases were retrieved from a study to estimate the
frequency of B19V seroconversion in a cohort of HIV-infected
patients.13 Written informed consent was obtained from all
participants and the project was approved by the Hospital
Review Board (CMM/HUAP 134/05).
For molecular detection of B19V and sequencing, viral
DNA was extracted from serum samples using a QIAamp
DNA Blood Mini Kit (QIAGEN, Hilden, Germany). Genotyp-
ing of B19V strains was performed with a semi-nested
PCR using the primer pairs P12/P16 (4127–4689) and P13/P16
(4214–4689) for partial ampliﬁcation of the VP1/VP2 cap-
sid gene.5 The 476-bp amplicons were puriﬁed using the
illustra GFXTM PCR DNA and Gel Band Puriﬁcation kit (GE,
Healthcare
®
, Buckinghamshire, UK) and then subjected to
direct sequencing using the BigDye terminator v. 1.1 cycle
sequencing kit (Applied Biosystems, CA, USA) and an ABI
Prism
®
3730 DNA analyzer (Applied Biosystems, CA, USA).
Both strands of each amplicon were sequenced at least twice.
The nucleotide sequences obtained during this study were
deposited in the GenBank database under accession numbers
KP115293–KP115325.Please cite this article in press as: Cubel Garcia RC, et al. Molecular div
infectiosum in Brazil. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bji
For sequence analysis and phylogeny, sequences were
aligned using the BioEdit Sequence Alignment Editor v7.2.5.
Phylogenetic trees were constructed by Bayesian Markov 6;x x x(x x):xxx–xxx
Chain Monte Carlo (MCMC) statistical framework imple-
mented in the BEAST v1.7.414 and maximum likelihood (ML)
available in the MEGA v.6.0 software.15 The evolutionary model
Hasegawa-Kishino-Yano plus gamma (HKY + ) was the sub-
stitution model used as the best ﬁtted by Model test 3.7.16
To determine the selection pressure acting at variable pos-
itions we  used the Fixed effects likelihood (FEL), Random effect
likelihood (REL) and Single likelihood ancestor counting (SLAC)
of the Datamonkey software.17
B19V infection was characterized by variable combinations
of fever, ﬂu-like symptoms, arthropathy, and gastrointesti-
nal symptoms. All cases presented with an erythematous
maculopapular rash. “Slappedcheek” appearance and reticu-
lar or lace-like rash were seen in only 30% of the children.
No adult presented this typical rash. Acute arthropathy was
reported more  frequently in adults, mainly in women, and in
general it was symmetrical, affecting preferentially the small
joints of the hands, feet, knees and wrists. In most of the cases
polyarthropathy completely resolved within two weeks. No
clinical manifestations of B19V infection were detected in the
medical records of the ﬁve HIV-infected adult patients during
the seroconversion period.
A 476 bp fragment of the B19V capsid gene was ampliﬁed by
PCR from 67/131 (51.1%) sera from patients with EI. The major-
ity of the positive samples were collected during the 1999–2000
(n = 40) and 2004–2005 (n = 23).
Nucleotide sequences of 27/67 ampliﬁed B19V DNA had a
satisfactory quality for analysis. All the 27 sequences detected
in EI patients belonged to subgenotype 1a (G1a) (Fig. 1).
Amongst the ﬁve B19V sequences obtained from the HIV-
infected patients, four (RJ109/2002, RJ011/2005, RJ026/2005,
RJ350/2006) were grouped into subgenotype G1a and the ﬁfth
sequence (RJ071/2005) into 3b (G3b). Of these ﬁve serum sam-
ples, three were collected during the 2004–2005 outbreak.
The phylogenetic tree supported the division of the G1a
in two well-deﬁned clades (posterior probability = 1). The
sequences from EI patients were distributed along the two
clades while 3/4 sequences from HIV-infected patients were
kept on the same clade (Fig. 1).
The average nucleotide distance observed between the G1a
sequences of this study with other G1a and G1b was 1.6% and
5.6%, respectively, and with G3b was 14.5%. Within subgeno-
type 1a, the viral sequences were more  closely related to
each other (d = 1.0%) than to G1a isolates from Brazil or other
countries (d = 1.2–1.8%). The nucleotide divergence between
the two G1a clades was 1.3% (amino acid divergence of 0.1%)
and the genetic distance within the clades was very low (p-
distance = 0.9% and 0.6%).
Comparison of the 427 bp fragment with G1a sequences
retrieved from GenBank revealed four nucleotide substitut-
ions at positions 4260 (A → T), 4267 (A → C), 4262 (A → T),
and 4552(T → C) that were identiﬁed only in strains of this
study during 1999–2000 outbreak (RJ674/1999, RJ676/1999,
RJ677/1999, RJ680/1999, RJ683/1999, RJ690/1999, RJ695/1999,
RJ/742/1999, RJ776/1999, RJ772/1999, RJ903/2000). Another four
changes at positions 4349 (C → T), 4414 (T → C), 4507(A → G)
and 4570 (C → T) were also found in Brazilian strains from Paráersity of human parvovirus B19 during two outbreaks of erythema
d.2016.11.002
and São Paulo. Among the eight nucleotide changes all but one
were synonymous (position 4260), a ﬁnding easily explained
since 6/8 changes occurred in the 3rd codon position.
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The examination of the selective pressures by the FEL, REL
nd SLAC algorithms of Datamonkey package demonstrated
hat the region is subject to strong negative selection. No pos-
tively select site was found.
One sequence (RJ071/2005) from a serum of an adult
emale HIV-infected patient receiving antiretroviral therapy
ho  seroconverted to anti-B19 IgG antibodies in September
005 showed more  than 14.5% of divergence with subgeno-
ype 1a in the 427 bp VP1/VP2 region, 12.2% with genotype 2
nd 1.8% with subgenotype 3b. The phylogenetic tree based
n these data showed that this sequence clustered in the
ame branch as others belonging to genotype 3b. It shared
igher nucleotide homology (99.8%) with other Brazilian 3bPlease cite this article in press as: Cubel Garcia RC, et al. Molecular div
infectiosum in Brazil. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bji
equences obtained from a patient with systemic lupus ery-
hematous from Pará (EF0892229/1999) and another with
nemia after a living-donor kidney transplant from São Paulo
AY647977/2004) (Fig. 2).5,9
ig. 1 – Phylogenetic analysis of B19V VP1/VP2 partial sequences
nfectiosum (blue) and HIV-infected patients (red) in Niterói, RJ, B
howed with their GenBank accession numbers in black. The Ba
elaxed molecular clock and the MCMC  analysis was run for 1 × 1;x  x x(x x):xxx–xxx 3
This analysis of B19V genotypes circulating from 1996 to
2006 was performed since there was a lack of information
regarding the genotypes of B19V circulating during outbreaks
of EI in Brazil. During the study period two distinct outbreaks
of B19V infection occurred: 1999–2000 and 2004–2005.6,7 We
demonstrated the predominance of subgenotype 1a. This is
consistent with previous studies performed in Brazil (North,
Midwest, South, and Southeast Brazil) in which the majority of
the sequences from sera of patients with acute B19V infection
belonged to subgenotype 1a.5,9,10,12 Sequences from subgeno-
type 1a of this study had average genetic diversity of 1.0% and
the diversity from 3b isolates was around 14.5%. These results
are consistent with previous studies in which the same region
3,4,5ersity of human parvovirus B19 during two outbreaks of erythema
d.2016.11.002
of VP1/VP2 gene was analyzed.
The ﬁrst evidence that two groups of subgenotype 1a coex-
ist around the world arose from the phylogenetic analysis
of strains from Dutch blood donors and patients with ﬁfth
 (427 bp), obtained from patients with erythema
razil, from 1996 to 2006. The reference sequences are
yesian Maximum Clade Credibility tree was based on the
09 generations to achieve the convergence of parameters.
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Fig. 2 – Maximum likelihood phylogenetic tree of 427 bp fragment of the VP1/VP2 capsid gene of B19V (Genotype 3b) based
on Hasegawa-Kishino-Yanoda plus gamma  (HKY + ) evolution model. Bootstraps values (>50%) based on 2000 replicates are
shown above the branches. The reference sequences are showed with their GenBank accession numbers.disease.18 The subdivision of subgenotype 1a into two groups
was also proposed by Freitas et al.5 in a study that analyzed the
same 427 bp fragment of VP1/VP2 region from patients with
several clinical manifestations of B19V infection in the Ama-
zon region (North Brazil). Recently, Slavov et al.12 examining a
446 bp fragment corresponding to the NS-1 gene of B19V from
patients with hemoglobinopathies and blood donors in the
State of São Paulo (Southeast Brazil) also reported the division
of subgenotype 1a into two clades.
In agreement with previous reports, these results show two
well-deﬁned clades into subgenotype 1a. The genetic distance
between the two clades was very low (d = 0.013) which is con-
sistent with other studies.5,18
The low diversity and occurrence of non-synonymous
substitutions of the strains G1a of this study may be explained
by: (i) all sera were from patients with acute infection6,7,13; (ii)
the majority of the sera were collected during two distinct
outbreaks; and (iii) almost all the nucleotide substitutions
occurred in the 3rd codon position which may not lead to
amino acid change.
Nucleotide changes might suggest temporal or geographicPlease cite this article in press as: Cubel Garcia RC, et al. Molecular div
infectiosum in Brazil. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bji
clustering but neither the genotypic grouping nor the co-
circulation of multiple lineages of G1a could be associated with
a particular outbreak. It is important to note that the ampliﬁedfragment correspond to the variable carboxy-terminal region
of VP1/VP2 capsid gene, a region that contains several neutral-
izing epitopes.1
Unlike acute infection, B19V isolates from patients with
persistent infection exhibit a higher degree of variability, both
at DNA and protein level, due to a low but continuous virus
replication over prolonged periods of time which may con-
tribute to accumulated mutations.1
The association of high nucleotide diversity with low
amino acid variability observed in B19V is consistent with
the apparent lack of difference in clinical manifestations and
antigenic reactivity in serological tests.1,3
In Brazil, all three B19V genotypes have been identiﬁed.
Whilst genotypes 1 and 3 have been detected in serum sam-
ples from patients with EI as well in sera and bone marrow
of patients with B19-related hematological symptoms,5,8–12
genotype 2 has only been detected in the bone marrow of older
patients (mean age 62.5 years) with cytopenias of unknown
origin.11,19
Surprisingly, a sequence obtained from a serum of an HIV-
infected patient during 2005 oubreak20 was characterized asersity of human parvovirus B19 during two outbreaks of erythema
d.2016.11.002
subgenotype 3b. The origin of this subgenotype is difﬁcult
to determine since the serum was collected during routine
follow-up examination of the patient under antiretroviral
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herapy. No travel information was available on medical
ecords. Furthermore, this is the ﬁrst report of genotype 3b
n the state of Rio de Janeiro, Southeast Brazil.
The predominance of genotype 1 (B19V), the low frequency
f genotype 3 and the absence of genotype 2 in our study
re similar to those previously found in other regions of
razil.5,8,9,11,12,19 As the PCR assay used ampliﬁes all three
enotypes of B19V, the lack of detection indicates the absence
f genotype 2 in these patients. Genotype 2 DNA has been
ound mostly in tissues of individuals born before 1960.2,19
ost sequences analyzed in this study were from acute infec-
ions in patients less than 40 years old.
The current study represents a further contribution to the
olecular characterization of B19V in Brazil since it presents
n analysis of the genotypes circulating during two distinct
utbreaks of erythema infectiosum in our country.
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